Eric Singhi, Thoracic Medical Oncologist and Assistant Professor at MD Anderson Cancer Center, shared a post on LinkedIn:
“Day 3 of Winter Lung 2026 kicks off with case discussions unpacking a gray zone in thoracic oncology: early-stage and locally advanced NSCLC.
Discussions included:
- How to approach synchronous primary tumors
- Expanding perioperative targeted therapy beyond EGFR and ALK
- How (and if) MRD status should influence adjuvant therapy decisions”
More posts featuring Eric K. Singhi on OncoDaily.